IP Library Granted Patent US 10,358,626
Granted Patent B2
US 10,358,626 · App. 15/485,866 · Granted Jul 23, 2019

Perfusion filtration systems

Inventors: Maurizio V. Cattaneo (Boston, MA); Remco A. Spanjaard (Brookline, MA)
Assignee: Artemis Biosystems, Inc.
C12M29/10B01D61/14B01D61/18B01D63/06B01D71/26C12M25/10C12M29/04C12M29/16B01D61/20B01D63/02B01D2315/10C07K2317/10C12N5/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,358,626
App. No.
15/485,866
Granted
Jul 23, 2019
Kind
B2
Abstract

Provided herein are tubular membrane filter elements, tangential flow filtration systems comprising such filter elements and methods of using such filter elements and filtration systems.

Claims (11)

1. A method of filtering a cell culture media comprising passing a cell culture media comprising mammalian cells and a virus through a plurality of tubular porous membranes of a filter elements enclosed within a casing,

wherein each tubular porous membrane filter element comprises a plurality of sintered tubular ultra-high-molecular-weight polyethylene (UHMWPE) porous membranes, wherein at least 95% of the pores in each of the plurality of tubular porous membranes are between 5 μm and −15 μm in size and wherein the internal diameter of each of the plurality of tubular porous membranes is between about 1 mm to about 10 mm,

wherein the mammalian cells are retained within the tubular porous membranes and a permeate comprising the virus flows through the pores of the tubular porous membranes into the casing.

2. The method of claim 1 , wherein at least 99% of the pores in each of the plurality of tubular porous membranes are between 5 μm and 15 μm in size.

3. The method of claim 1 , wherein at least 95% of the pores in each of the plurality of tubular porous membranes are between of 7 μm and 12 μm in size.

4. The method of claim 1 , wherein the internal diameter of each of the plurality of tubular porous membranes is between about 1 mm and about 5 mm.

5. The method of claim 1 , wherein the virus is a lentivirus, an adeno-associated virus (AAV), and/or an influenza virus.

6. The method of claim 1 , wherein the casing has an internal diameter of about 1 to about 30 cm.

7. The method of claim 1 , wherein the plurality of tubular porous membranes comprises at least 9 tubular porous membranes.

8. The method of claim 1 , wherein the method is a tangential flow filtration perfusion method or an alternating tangential flow perfusion method.

9. The method of claim 1 , wherein the virus is a lentivirus.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2017
From: CATTANEO, MAURIZIO V.; SPANJAARD, REMCO A.
To: ARTEMIS BIOSYSTEMS, INC.
Reel/Frame 042320/0832 →
Continuity (2)
Provisional Application 62321234 · Apr 12, 2016
Related Publication 20170292103A1 · Oct 12, 2017
Cited By (1)
US 12,708,876